Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

Reprogramming the immune response to peanut in established peanut allergy.

FY 2018-19

Summary
Some food allergies, like those to peanuts, are maintained for a lifetime in up to 80% of individuals. Currently, no curative interventions exist, only drugs that mitigate symptoms or are given post-anaphylaxis. Immune responses to food allergens are mediated by antibodies, namely IgE. However, IgE and IgE-producing cells vanish shortly after allergen exposure, thus other allergen-specific cells must persist. Recently it has been demonstrated that allergen-specific memory B cells are maintained for a lifetime and, under specific stimuli, these cells can transition into IgE-producing cells. One such stimuli is IL-4, a small protein secreted by numerous immune cells with critical involvement in allergic disease and IgE production. We hypothesize that blockade of the IL-4 receptor will not only suppress the production of IgE but will also promote a shift from a deleterious response to a protective immune response. To investigate this, we will first identify the cell type(s) that contribute to IL-4 production in a recall response in a mouse model. Subsequently, two novel platforms will be used to assess the effect of IL-4 receptor blockade. One platform involves mice that uniquely model peanut allergy with human immune cells. Here we will measure the production of peanut-specific IgE following treatment with an IL-4 receptor block. Next, human immune cells from the blood of peanut-allergic individuals will be cultured in the presence or absence of IL-4 receptor block. The production of other non-allergy, allegedly protective, antibodies and changes in gene expression and protein secretion will be investigated. There has been little advancement in the treatment of food allergy, despite a relatively well-characterized understanding of underlying immunological mechanisms. IL-4 is positioned as a key molecule in the maintenance of lifelong food allergy. Therefore, this research is critical for the identification of therapeutic targets with disease-transforming potential.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
404109
Name
Bruton Kelly
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Reprogramming the immune response to peanut in established peanut allergy.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Anaphylaxis; Antibodies; Children'S Health; Cytokines; Flow Cytometry; Food Allergy; Ige; Immune Memory; Immunology; Therapeutic
Abstract
Some food allergies, like those to peanuts, are maintained for a lifetime in up to 80% of individuals. Currently, no curative interventions exist, only drugs that mitigate symptoms or are given post-anaphylaxis. Immune responses to food allergens are mediated by antibodies, namely IgE. However, IgE and IgE-producing cells vanish shortly after allergen exposure, thus other allergen-specific cells must persist. Recently it has been demonstrated that allergen-specific memory B cells are maintained for a lifetime and, under specific stimuli, these cells can transition into IgE-producing cells. One such stimuli is IL-4, a small protein secreted by numerous immune cells with critical involvement in allergic disease and IgE production. We hypothesize that blockade of the IL-4 receptor will not only suppress the production of IgE but will also promote a shift from a deleterious response to a protective immune response. To investigate this, we will first identify the cell type(s) that contribute to IL-4 production in a recall response in a mouse model. Subsequently, two novel platforms will be used to assess the effect of IL-4 receptor blockade. One platform involves mice that uniquely model peanut allergy with human immune cells. Here we will measure the production of peanut-specific IgE following treatment with an IL-4 receptor block. Next, human immune cells from the blood of peanut-allergic individuals will be cultured in the presence or absence of IL-4 receptor block. The production of other non-allergy, allegedly protective, antibodies and changes in gene expression and protein secretion will be investigated. There has been little advancement in the treatment of food allergy, despite a relatively well-characterized understanding of underlying immunological mechanisms. IL-4 is positioned as a key molecule in the maintenance of lifelong food allergy. Therefore, this research is critical for the identification of therapeutic targets with disease-transforming potential.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bruton, Kelly
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McMaster University - $105,000 Grant (2018-19) | Canada Spends